With the U.S. measles elimination status in jeopardy, the outbreak’s epicenter sees little urgency
From The Cancer Letter · 00:30:30
Show by The Cancer Letter
The United States is projected to lose its measles elimination status, marking a troubling reversal after more than two decades in which the virus was no longer considered endemic.At the center of the outbreak is Pennsylvania, particularly Lancaster County, where nearly 500 of the state’s 1,500 cases have been reported. The outbreak is concentrated in the largely unvaccinated Amish and Plain communities. But its consequences extend well beyond those communities, especially to people whose immune systems are compromised by cancer, treatment, or other serious illnesses. On this episode of The Cancer Letter Podcast, Jacquelyn Cobb, managing editor of The Cancer Letter speaks with Claire Marie Porter, reporter, who lives in Lancaster County, the outbreak’s epicenter. Claire describes what it's like to cover a public health crisis from inside the community, and the striking absence of urgency she has encountered. For cancer patients, measles is more than a public health concern, it’s a reminder of how much their safety depends on the choices of people around them. "Anyone who's ever been in that type of situation knows how important the collective behavior of strangers is and how much you rely on other people to tell you when they're sick and to be honest and to vaccinate themselves in order to protect you,” Claire said.Yet, in the middle of an escalating outbreak, are hospitals and cancer centers prepared? Are they updating infection-control protocols, reconsidering masking or screening, thinking about the patients who are least able to protect themselves? Pennsylvania has yet to declare a state of emergency, which would accelerate the public health response. “I think I realized, ‘Oh, maybe that's why I'm struggling so much with this story is because no one's talking about it. There's no sense of urgency,’” Claire said. “There have been some minor changes, but I think there's this overall very strong resistance to taking temperatures at doors and masking and all that because of COVID. People are still really jaded by how that was handled. There's just this resistance.”Stories mentioned in this podcast include: In the epicenter of the measles outbreak, “love thy neighbor” does not extend to vaccination ratesDemocrats vow to undo Trump’s Medicaid cuts, reverse ACA dismantlingAs Iowa goes blue, incoming Gov. Rob Sand and Sen. Josh Turek offer plans to address the state’s “cancer crisis”David Hohn, former president and CEO of Roswell Park, dies at 84Four of eight new USPSTF members allowed to keep financial conflicts of interestA transcript of this podcast is available: https://cancerletter.com/podcastc/20261111-measles/
More episodes of The Cancer Letter
More episodes
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- Philadelphia cancer center directors talk city-wide collaboration: “A bench-to-bedside-to-block model”
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- Cercek: “The majority of patients in AZUR-1 in a global study were able to avoid all of standard of care”
- Cancer breakthroughs hit the clinic, cancer policy hits the ballot box
- The Directors: VCU’s Baskin and UNC’s Ferris weigh oncology’s looming dilemma—MCDs
- As USPSTF falters and FDA ignores clinical benefit, “the idea that screening is always good is probably gaining traction right now”
- As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”
- The Galleri MCD vote: What FDA asked its advisors to ignore
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.